This episode of Casual Conversations, led by John Malanca of the Association of Cannabinoid Specialists, features Dr. Adam Abodeely, Dr. Suraj Tandon, and Dr. Jordan Tishler addressing the critical need for medical supervision in the use of cannabis as medicine.

In this discussion, Dr. Jordan Tishler, a Harvard-educated physician with extensive experience in internal and emergency medicine, shares his insights and advocacy for a more medical-oriented cannabis system.

Many clinicians have never actually been inside a dispensary nor have a good working knowledge of the products that are available there.  This tour aims to facilitate understanding of what your patients will encounter when they go to get their medicine. 

https://www.youtube.com/watch?v=jVxEclvhcF0

The webinar, sponsored by the Attorneys and Judges Council and hosted by Hadassah's Professional Councils Chair, Carol Greenfield, features Dr. Jordan Tishler discussing the medical use and legislative landscape of cannabis.

In this discussion, hosted by John Malanca from the Association of Cannabinoid Specialists, Dr. Jordan Tishler explores the complexities of hemp regulation and the medical implications of cannabinoid use.

While cannabis as medicine is not new, the healthcare provider’s venture into the cannabis industry may be a new journey for many. In state medical marijuana programs doctors are the people who “recommend” cannabis (presently there is no actual prescription for cannabis).

The Association of Cannabinoid Specialists (ACS) is an international non-profit organization of physicians and other health professionals specializing in using cannabis or cannabinoids, as appropriate, for the care and treatment of patients suffering from a range of debilitating conditions such as cancer, Crohn’s disease, AIDS, multiple sclerosis, Parkinson’s disease, epilepsy, autism, and post-traumatic stress disorder, and patients with terminal illnesses.

Now that recreational cannabis is rolling out in Massachusetts, why do we need a medical cannabis system anymore? The short answer is that patients are different from recreational users and have more complicated, precise needs that recreational sales are incapable of handling.

The ACS believes that cannabis dispensaries play a vital role in providing care and products to patients.  Ideally, dispensaries provide access to high-quality, regulated, and tested cannabis in appropriate forms and for use in appropriate routes of administration to meet patients’ medical needs.

While a patchwork of state cannabis laws exists, the lack of a unified, federal framework regulating medical cannabis places patients at risk, and undermines the relationships that doctors must maintain to ensure an effective and safe treatment paradigm.  Such a framework is both overdue and sorely needed for safe, optimized care of patients across the country.